Patient Characteristics
Know your Numbers
Comorbidities
Provider Characteristics
Market Development
100

Likely due to the auto-anesthetic effect of cryoablation, the median ______ score was 2/10 during treatment with Cerene in the CLARITY study

PAIN

100

ITT Success rate

77%

100

Characterized by symptoms of dysmenorrhea, chronic pelvic pain, and irregular bleeding, this condition causes tissue similar to endometrium to grow outside of the uterus

Endometriosis

100

A physician who has a past history of treating HMB

Past ablator 

100

Event held to educate and drive awareness to patients

Patient event  

200

Also known as “painful menstruation” or “period cramps,” this was reduced 86% one year after treatment with Cerene in patients experiencing it at a severe/very severe level before treatment

Dysmenorrhea

200

Hysterectomy rate due to continued bleeding after 3 years

3%

200

Characterized by symptoms of dysmenorrhea and heavy menstrual bleeding, this condition causes endometrium to grow into the myometrium

Adenomyosis

200

A physician who has this type of modality in their practice

Current ablator

200

An event used to expand users, referrals and knowledge 

Physician dinner 

300

All treatments in the CLARITY Study were performed using this form of local anesthesia

Paracervical Block

300

Cavity access

99%

300

Safety and effectiveness of the Cerene Cryotherapy Device has not been fully evaluated in submucous or cavity-distorting ____

Fibroids 

300

Catalysts for transformation, bridging the gap between patient care and industry to improve healthcare delivery

Innovator/early adopter 

300

Marketing tactic used to target existing patient population in facility with specific diagnosis codes

ICD 10 


400

“Parturition” and “accouchement” are both synonyms for this, which a woman must have concluded to be eligible for treatment with Cerene.

Childbearing

400

Average procedure time

7 Minutes

400

Safety and effectiveness of the Cerene Cryotherapy Device has not been fully evaluated in patients with _______  greater than 1 cm

Polyps

400

Physician who proactively supports, promotes, and leads new initiatives,, technologies, or practice improvements within a healthcare organization

Champion 


400

Resource to drive patient education, office education and drive consultations

Nurse advocate 


500

This condition, defined as the accumulation of menstrual blood due to an obstruction in outflow, was not seen following Cerene treatment in the CLARITY pivotal study

Hematometra

500

Number of days patients returned to normal daily activity

  1 day

500

35.5% of patients in the CLARITY study had a previous _______

(Low transverse) cesarean section

500

A physician who owns or works in an independent, community-based office, primarily focusing on long-term, outpatient, and preventive

Private practice

500

Resource to drive utilization and awareness directly with customers

Market Development Manager